`Brain Decade' Neuroscientists Court Support

For funding to keep pace with the field's progress, researchers work to keep the public aware of their discipline's achievements When the Society for Neuroscience meets this week in St. Louis, the group's 18,000 members will have their first opportunity to reflect on the first year of the Decade of the Brain, a designation given the 1990s by Congress and President Bush in recognition of the need to better understand mental and neurological disorders. About 50 million people in the United Stat

Written byElizabeth Pennisi
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

When the Society for Neuroscience meets this week in St. Louis, the group's 18,000 members will have their first opportunity to reflect on the first year of the Decade of the Brain, a designation given the 1990s by Congress and President Bush in recognition of the need to better understand mental and neurological disorders. About 50 million people in the United States suffer from such maladies at an annual cost of $305 billion in treatment, care, and lost productivity.

Although those numbers aren't about to shrink, scientists are cheering the field's progress. It's estimated that 90 percent of what is known about the nervous system has been learned during the past 10 years. That knowledge has provided many clues about how the brain works and has firmly established a biological basis for mental disorders, thereby removing some of the stigma that accompanies such a diagnosis. "It's the hottest, fastest moving, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies